Arrowgrass Capital Partners (US)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,255
Closed -$231K 240
2019
Q2
$231K Buy
+2,255
New +$231K 0.01% 229